Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine for Insulin Secretion in Type 2 Diabetes
NCT01249677Phase 4Completed
- Sponsor
- Ruhr University Bochum
- Start
- Jan 2009
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Ruhr University Bochum. Started Jan 2009; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01249677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01249677.